Abstract
Abstract: Brinzolamide is a treatment option for glaucoma. As glaucoma is the third leading cause of blindness, there is a need for analytical methods to obtain an effective drug with great precision and accuracy. Even if brinzolamide is official in IP and USP, different analytical methods still need to be brought in one place, which would help attain better results and easy comparison for other analysis specifications and procedures. This review helps to understand and gather different analysis techniques or biological fluid techniques of brinzolamide in a dosage form. These techniques include UV spectroscopy, HPLC, LC-MS, and TLC densitometry.
Keywords: Brinzolamide, glaucoma, analytical method, UV, HPLC, LC-MS.
Graphical Abstract
[1]
IAPB. Available from: https://www.iapb.org/learn/our-events/focus-on-glaucomaAccessedMarch 5, 2021.
[2]
IAPB. Available from: https://www.iapb.org/learn/vision-atlas/causes-of-vision-loss/AccessedMarch 5, 2021.
[3]
Glaucoma Patients. Available from: https://www.glaucomapatients.org/basic/how-does-glaucoma-evolve/AccessedMarch 5, 2021.
[4]
Cvetkovic, R.S.; Perry, C.M. Brinzolamide: a review of its use in the management of primary open-angle glaucoma and ocular hypertension. Drugs Aging, 2003, 20(12), 919-947.
[http://dx.doi.org/10.2165/00002512-200320120-00008] [PMID: 14565787]
[http://dx.doi.org/10.2165/00002512-200320120-00008] [PMID: 14565787]
[5]
Bhalerao, H.; Koteshwara, K.B.; Chandran, S. Design, optimisation and evaluation of in situ gelling nanoemulsion formulations of brinzolamide. Drug Deliv. Transl. Res., 2020, 10(2), 529-547.
[http://dx.doi.org/10.1007/s13346-019-00697-0] [PMID: 31820300]
[http://dx.doi.org/10.1007/s13346-019-00697-0] [PMID: 31820300]
[6]
Kadam, R.S.; Jadhav, G.; Ogidigben, M.; Kompella, U.B. Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow. Drug Metab. Dispos., 2011, 39(9), 1529-1537.
[http://dx.doi.org/10.1124/dmd.111.040055] [PMID: 21673129]
[http://dx.doi.org/10.1124/dmd.111.040055] [PMID: 21673129]
[7]
Brittain, H.G.; Florey, K. Analytical Profiles of Drug Substances and Excipients: Preface. Anal. Profiles Drug Subst. Excipients, 1992, 21(C)
[http://dx.doi.org/10.1016/S0099-5428(08)60386-X]
[http://dx.doi.org/10.1016/S0099-5428(08)60386-X]
[8]
Indian Pharmacopoeia. Vol 2. Eigth. Ghaziabad: The Indian pharmacopoeia Commission, Ghaziabad 2018.
[9]
Pharmacopeia, U.S. National Formulary: USP 41—NF 36. In: Carbomer Homopolymer; United States Pharmacopeial Convention: Rockville, MD, USA , 2018. p. 5257
[10]
Chanam, M.D.; Pratap, K.; Dutta, R.S. Development and validation of simple Uv spectrophotometric method for estimation of brinzolamide. J. Pharm. Sci. Innov., 2019, 8(2), 60-63.
[http://dx.doi.org/10.7897/2277-4572.082129]
[http://dx.doi.org/10.7897/2277-4572.082129]
[11]
Sujatha, G.; Yadagiri Swami, P.; Venkateshwarlu, G. Spectrophotometric determination of drugs in bulk and in pharmaceutical dosage forms by using tetracyanoethylene. Mater. Today Proc., 2016, 3(10), 3652-3659.
[http://dx.doi.org/10.1016/j.matpr.2016.11.009]
[http://dx.doi.org/10.1016/j.matpr.2016.11.009]
[12]
Agrawal, V.P.; Desai, S.S.; Jani, G.K. Development of ultraviolet spectrophotometric method for the simultaneous estimation of brimonidine tartrate and brinzolamide. Indian Drugs, 2015, 52(11), 29-34.
[13]
Vijay, P.; Patel, D.; Desai, S.; Meshram, D. Development and validation of derivative spectrophotometric method for simultaneous estimation of brimonidine tartrate and brinzolamide in combined dosage form. Indo American J. Pharm. Res., 2014, 4(3), 1472-1478.
[14]
Ibrahim, F.A.; Elmansi, H.M.; El Abass, S.A. A versatile HPLC method with an isocratic single mobile phase system for simultaneous determination of anti-glaucoma formulations containing timolol. Ann. Pharm. Fr., 2019, 77(4), 302-312.
[http://dx.doi.org/10.1016/j.pharma.2019.02.005] [PMID: 31027754]
[http://dx.doi.org/10.1016/j.pharma.2019.02.005] [PMID: 31027754]
[15]
Tiwari, B.; Shirsat, M.K.; Kulkarni, A. Analytical method development and validation for the determination of Brinzolamide by RP-HPLC. J. Drug Deliv. Ther., 2020, 10(1), 92-96.
[http://dx.doi.org/10.22270/jddt.v10i1.3845]
[http://dx.doi.org/10.22270/jddt.v10i1.3845]
[16]
Agrawal, V.P.; Desai, S.S.; Jani, G.K. Development of RP-HPLC method for simultaneous determination of brimonidine tartrate and brinzolamide by QbD approach and its validation. Eurasian J. Anal. Chem., 2016, 11(2), 63-78.
[http://dx.doi.org/10.12973/ejac.2016.122a]
[http://dx.doi.org/10.12973/ejac.2016.122a]
[17]
Hassib, S.T.; Elkady, E.F.; Sayed, R.M. Simultaneous determination of timolol maleate in combination with some other anti-glaucoma drugs in rabbit aqueous humor by high performance liquid chromatography-tandem mass spectroscopy. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2016, 1022, 109-117.
[http://dx.doi.org/10.1016/j.jchromb.2016.04.012] [PMID: 27085020]
[http://dx.doi.org/10.1016/j.jchromb.2016.04.012] [PMID: 27085020]
[18]
Kostić, N.; Dotsikas, Y.; Jović, N.; Stevanović, G.; Malenović, A.; Medenica, M. Quantitation of pregabalin in dried blood spots and dried plasma spots by validated LC-MS/MS methods. J. Pharm. Biomed. Anal., 2015, 109, 79-84.
[http://dx.doi.org/10.1016/j.jpba.2015.02.023] [PMID: 25767905]
[http://dx.doi.org/10.1016/j.jpba.2015.02.023] [PMID: 25767905]
[19]
Eissa, M.S.; Nour, I.M.; Elghobashy, M.R.; Shehata, M.A. Validated TLC-densitometry method for simultanouse determination of brinzolamide and timolol in their ophthalmic preparation. Anal. Chem. Lett., 2017, 7(6), 805-812.
[http://dx.doi.org/10.1080/22297928.2017.1395294]
[http://dx.doi.org/10.1080/22297928.2017.1395294]
Article Metrics
16
1